Venous Thromboembolism in Advanced Lung Cancer (RIVAL)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03581708|
Recruitment Status : Not yet recruiting
First Posted : July 10, 2018
Last Update Posted : July 10, 2018
|Condition or disease||Intervention/treatment|
|Lung Neoplasms Venous Thromboembolism||Other: lung cancer|
|Study Type :||Observational|
|Estimated Enrollment :||1400 participants|
|Official Title:||Real-world Study of the Incidence and Risk Factors of Venous Thromboembolism (VTE) in Chinese Advanced Stage Lung Cancer|
|Estimated Study Start Date :||July 2018|
|Estimated Primary Completion Date :||June 2021|
|Estimated Study Completion Date :||June 2022|
advanced lung cancer
Patients diagnosed with advanced lung cancer
Other: lung cancer
If the patient is diagnosed with lung cancer in advanced stage, he/she will be followed up for VTE incidence
Other Name: advance lung cancer
- VTE incidence risk evaluation [ Time Frame: 12 months ]Real world VTE incidence risk evaluation in advanced lung cancer. Establish and validate VTE risk predictive model in Chinese advanced lung cancer.
- VTE incidence [ Time Frame: 12 months ]VTE incidence in advanced lung cancer.
- VTE and overall survival [ Time Frame: 12 months ]The influence on overall survival by VTE.
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03581708
|Contact: ZHEN WANG, PhD||862083827812 ext firstname.lastname@example.org|
|Contact: XIAOLING CHEN||8620-83827812 ext email@example.com|
|Guangdong General Hospital||Not yet recruiting|
|Guangzhou, Guagndong, China, 510080|
|Contact: ZHEN WANG, PhD 862083827812 ext 50811 firstname.lastname@example.org|
|Contact: XIAOLING CHEN 862083827812 ext 50812 email@example.com|
|Principal Investigator: ZHEN WANG, PHD|
|Principal Investigator:||ZHEN WANG||Guangdong General Hospital, Guangdong Academy of Medical Sciences|